Global Endowment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-54,600
Closed -$4.22M 227
2018
Q1
$4.22M Buy
+54,600
New +$4.4M 0.61% 30
2017
Q1
Sell
-39,130
Closed -$2.88M 258
2016
Q4
$2.88M Sell
39,130
-6,700
-15% -$499K 0.45% 29
2016
Q3
$3.68M Buy
+45,830
New +$3.67M 0.61% 29

Other funds holding LLY

Global Endowment Management's LLY Position: Q2 2018 in Review

Global Endowment Management sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 54,600 shares — an estimated $4.22M sold.

Global Endowment Management first reported a position in LLY in Q3 2016 and held it in 3 quarters. The position peaked at $4.22M in Q1 2018. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Global Endowment Management reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Global Endowment Management sold 54,600 Eli Lilly shares in Q2 2018, an estimated $4.22M.
  • Global Endowment Management first reported a position in Eli Lilly in Q3 2016 and held it in 3 quarters.
  • Global Endowment Management's Eli Lilly position peaked at $4.22M in Q1 2018.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Global Endowment Management's 13F filing for Q2 2018, filed 10 Aug 2018.